Colorectal Cancer Toolkit for Colon Cancer Screening

Phase-Based Progress Estimates
Colon Cancer ScreeningColorectal Cancer Toolkit - Other
45 - 75
All Sexes
What conditions do you have?

Study Summary

This trial is testing a multilevel intervention to improve follow-up rates for positive fecal immunochemical tests (FITs), which are used to screen for colorectal cancer (CRC). The intervention is being implemented in a rural, underserved area in Southern Illinois.

Eligible Conditions
  • Colon Cancer Screening

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 3 Secondary · Reporting Duration: Completion of follow-up (estimated to be 44 months)

Month 44
Number of colonoscopy completions after positive fecal immunochemical test
Number of referrals for colonoscopies after positive fecal immunochemical test
Proportion of participants who initiate a colonoscopy within 14 days of positive fecal immunochemical test
Proportion of patients who complete a complete diagnostic evaluation within 60 days of positive fecal immunochemical test
Time to colonoscopy

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Primary Care Clinics
1 of 1

Experimental Treatment

83573 Total Participants · 1 Treatment Group

Primary Treatment: Colorectal Cancer Toolkit · No Placebo Group · N/A

Primary Care Clinics
Experimental Group · 1 Intervention: Colorectal Cancer Toolkit · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: completion of follow-up (estimated to be 44 months)

Who is running the clinical trial?

National Institutes of Health (NIH)NIH
2,440 Previous Clinical Trials
24,483,838 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,069 Previous Clinical Trials
41,045,835 Total Patients Enrolled
Washington University School of MedicineLead Sponsor
1,803 Previous Clinical Trials
2,195,876 Total Patients Enrolled
2 Trials studying Colon Cancer Screening
1,290 Patients Enrolled for Colon Cancer Screening
Aimee James, Ph.D., MPHPrincipal InvestigatorWashington University School of Medicine
1 Previous Clinical Trials
431 Total Patients Enrolled

Eligibility Criteria

Age 45 - 75 · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
The sites must be able to provide a broad range of primary care services, including both medical and dental care
(SIH) has agreed to a five-year contract with the federal government to provide healthcare services to veterans in southern Illinois

Who else is applying?

What state do they live in?
What site did they apply to?
Washington University School of Medicine100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%